Characteristics of sweet syndrome in patients with acute myeloid leukemia

Syed M. Kazmi, Naveen Pemmaraju, Keyur P. Patel, Philip R. Cohen, Naval Daver, Kathy M. Tran, Farhad Ravandi, Madeleine Duvic, Guillermo Garcia-Manero, Sherry Pierce, Aziz Nazha, Gautam Borthakur, Hagop Kantarjian, Jorge Cortes

Research output: Contribution to journalArticle

Abstract

Introduction Sweet syndrome (SS) is associated with hematologic malignancies including acute myeloid leukemia (AML). Patients and Methods Records of patients with AML treated at our institution were reviewed to identify those with SS. Patient characteristics, laboratory values, and cytogenetic and molecular abnormalities were retrospectively reviewed. Results We identified 21 of 2178 (1%) AML patients who demonstrated clinical signs and symptoms, and histological features consistent with SS. Eleven patients (52%) were classified as AML with myelodysplasia-related features and 3 patients had therapy-related AML. Three patients had received treatment with granulocyte colony stimulation factor, 1 patient liposomal all-trans-retinoic acid, and 2 patients received hypomethylating agents before development of SS. Cytogenetic analysis revealed diploid karyotype in 7 patients (33%); -5/del(5q) in 8 patients (38%): 3 patients had -5/del(5q) as the sole abnormality and 5 patients had -5/del(5q) as part of complex cytogenetics; and complex cytogenetics in 5 patients (24%). Gene mutations in FMS-related tyrosine kinase-3 (FLT3) gene were identified in 7 of 18 evaluable patients (39%), including FLT3-internal tandem duplication in 4 patients and FLT3-D835 tyrosine kinase domain mutation in 3 patients. Conclusion SS occurs in 1% of AML patients; -5/del(5q) karyotype, FLT3 mutations, and AML with myelodysplasia-related features were more frequent among patients with SS.

Original languageEnglish (US)
Pages (from-to)358-363
Number of pages6
JournalClinical Lymphoma, Myeloma and Leukemia
Volume15
Issue number6
DOIs
StatePublished - Jun 1 2015
Externally publishedYes

Fingerprint

Sweet Syndrome
Acute Myeloid Leukemia
Karyotype
Cytogenetics
Protein-Tyrosine Kinases
Mutation

Keywords

  • -5/del(5q)
  • Acute febrile neutrophilic dermatosis
  • FMS-related tyrosine kinase-3
  • Myelodysplastic syndrome
  • Neutrophilic dermatosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Characteristics of sweet syndrome in patients with acute myeloid leukemia. / Kazmi, Syed M.; Pemmaraju, Naveen; Patel, Keyur P.; Cohen, Philip R.; Daver, Naval; Tran, Kathy M.; Ravandi, Farhad; Duvic, Madeleine; Garcia-Manero, Guillermo; Pierce, Sherry; Nazha, Aziz; Borthakur, Gautam; Kantarjian, Hagop; Cortes, Jorge.

In: Clinical Lymphoma, Myeloma and Leukemia, Vol. 15, No. 6, 01.06.2015, p. 358-363.

Research output: Contribution to journalArticle

Kazmi, SM, Pemmaraju, N, Patel, KP, Cohen, PR, Daver, N, Tran, KM, Ravandi, F, Duvic, M, Garcia-Manero, G, Pierce, S, Nazha, A, Borthakur, G, Kantarjian, H & Cortes, J 2015, 'Characteristics of sweet syndrome in patients with acute myeloid leukemia', Clinical Lymphoma, Myeloma and Leukemia, vol. 15, no. 6, pp. 358-363. https://doi.org/10.1016/j.clml.2014.12.009
Kazmi, Syed M. ; Pemmaraju, Naveen ; Patel, Keyur P. ; Cohen, Philip R. ; Daver, Naval ; Tran, Kathy M. ; Ravandi, Farhad ; Duvic, Madeleine ; Garcia-Manero, Guillermo ; Pierce, Sherry ; Nazha, Aziz ; Borthakur, Gautam ; Kantarjian, Hagop ; Cortes, Jorge. / Characteristics of sweet syndrome in patients with acute myeloid leukemia. In: Clinical Lymphoma, Myeloma and Leukemia. 2015 ; Vol. 15, No. 6. pp. 358-363.
@article{56ecbf800a464661bfdfaefdbd63b8bf,
title = "Characteristics of sweet syndrome in patients with acute myeloid leukemia",
abstract = "Introduction Sweet syndrome (SS) is associated with hematologic malignancies including acute myeloid leukemia (AML). Patients and Methods Records of patients with AML treated at our institution were reviewed to identify those with SS. Patient characteristics, laboratory values, and cytogenetic and molecular abnormalities were retrospectively reviewed. Results We identified 21 of 2178 (1{\%}) AML patients who demonstrated clinical signs and symptoms, and histological features consistent with SS. Eleven patients (52{\%}) were classified as AML with myelodysplasia-related features and 3 patients had therapy-related AML. Three patients had received treatment with granulocyte colony stimulation factor, 1 patient liposomal all-trans-retinoic acid, and 2 patients received hypomethylating agents before development of SS. Cytogenetic analysis revealed diploid karyotype in 7 patients (33{\%}); -5/del(5q) in 8 patients (38{\%}): 3 patients had -5/del(5q) as the sole abnormality and 5 patients had -5/del(5q) as part of complex cytogenetics; and complex cytogenetics in 5 patients (24{\%}). Gene mutations in FMS-related tyrosine kinase-3 (FLT3) gene were identified in 7 of 18 evaluable patients (39{\%}), including FLT3-internal tandem duplication in 4 patients and FLT3-D835 tyrosine kinase domain mutation in 3 patients. Conclusion SS occurs in 1{\%} of AML patients; -5/del(5q) karyotype, FLT3 mutations, and AML with myelodysplasia-related features were more frequent among patients with SS.",
keywords = "-5/del(5q), Acute febrile neutrophilic dermatosis, FMS-related tyrosine kinase-3, Myelodysplastic syndrome, Neutrophilic dermatosis",
author = "Kazmi, {Syed M.} and Naveen Pemmaraju and Patel, {Keyur P.} and Cohen, {Philip R.} and Naval Daver and Tran, {Kathy M.} and Farhad Ravandi and Madeleine Duvic and Guillermo Garcia-Manero and Sherry Pierce and Aziz Nazha and Gautam Borthakur and Hagop Kantarjian and Jorge Cortes",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.clml.2014.12.009",
language = "English (US)",
volume = "15",
pages = "358--363",
journal = "Clinical Lymphoma, Myeloma and Leukemia",
issn = "2152-2650",
publisher = "Cancer Media Group",
number = "6",

}

TY - JOUR

T1 - Characteristics of sweet syndrome in patients with acute myeloid leukemia

AU - Kazmi, Syed M.

AU - Pemmaraju, Naveen

AU - Patel, Keyur P.

AU - Cohen, Philip R.

AU - Daver, Naval

AU - Tran, Kathy M.

AU - Ravandi, Farhad

AU - Duvic, Madeleine

AU - Garcia-Manero, Guillermo

AU - Pierce, Sherry

AU - Nazha, Aziz

AU - Borthakur, Gautam

AU - Kantarjian, Hagop

AU - Cortes, Jorge

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Introduction Sweet syndrome (SS) is associated with hematologic malignancies including acute myeloid leukemia (AML). Patients and Methods Records of patients with AML treated at our institution were reviewed to identify those with SS. Patient characteristics, laboratory values, and cytogenetic and molecular abnormalities were retrospectively reviewed. Results We identified 21 of 2178 (1%) AML patients who demonstrated clinical signs and symptoms, and histological features consistent with SS. Eleven patients (52%) were classified as AML with myelodysplasia-related features and 3 patients had therapy-related AML. Three patients had received treatment with granulocyte colony stimulation factor, 1 patient liposomal all-trans-retinoic acid, and 2 patients received hypomethylating agents before development of SS. Cytogenetic analysis revealed diploid karyotype in 7 patients (33%); -5/del(5q) in 8 patients (38%): 3 patients had -5/del(5q) as the sole abnormality and 5 patients had -5/del(5q) as part of complex cytogenetics; and complex cytogenetics in 5 patients (24%). Gene mutations in FMS-related tyrosine kinase-3 (FLT3) gene were identified in 7 of 18 evaluable patients (39%), including FLT3-internal tandem duplication in 4 patients and FLT3-D835 tyrosine kinase domain mutation in 3 patients. Conclusion SS occurs in 1% of AML patients; -5/del(5q) karyotype, FLT3 mutations, and AML with myelodysplasia-related features were more frequent among patients with SS.

AB - Introduction Sweet syndrome (SS) is associated with hematologic malignancies including acute myeloid leukemia (AML). Patients and Methods Records of patients with AML treated at our institution were reviewed to identify those with SS. Patient characteristics, laboratory values, and cytogenetic and molecular abnormalities were retrospectively reviewed. Results We identified 21 of 2178 (1%) AML patients who demonstrated clinical signs and symptoms, and histological features consistent with SS. Eleven patients (52%) were classified as AML with myelodysplasia-related features and 3 patients had therapy-related AML. Three patients had received treatment with granulocyte colony stimulation factor, 1 patient liposomal all-trans-retinoic acid, and 2 patients received hypomethylating agents before development of SS. Cytogenetic analysis revealed diploid karyotype in 7 patients (33%); -5/del(5q) in 8 patients (38%): 3 patients had -5/del(5q) as the sole abnormality and 5 patients had -5/del(5q) as part of complex cytogenetics; and complex cytogenetics in 5 patients (24%). Gene mutations in FMS-related tyrosine kinase-3 (FLT3) gene were identified in 7 of 18 evaluable patients (39%), including FLT3-internal tandem duplication in 4 patients and FLT3-D835 tyrosine kinase domain mutation in 3 patients. Conclusion SS occurs in 1% of AML patients; -5/del(5q) karyotype, FLT3 mutations, and AML with myelodysplasia-related features were more frequent among patients with SS.

KW - -5/del(5q)

KW - Acute febrile neutrophilic dermatosis

KW - FMS-related tyrosine kinase-3

KW - Myelodysplastic syndrome

KW - Neutrophilic dermatosis

UR - http://www.scopus.com/inward/record.url?scp=84931050305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931050305&partnerID=8YFLogxK

U2 - 10.1016/j.clml.2014.12.009

DO - 10.1016/j.clml.2014.12.009

M3 - Article

C2 - 25630528

AN - SCOPUS:84931050305

VL - 15

SP - 358

EP - 363

JO - Clinical Lymphoma, Myeloma and Leukemia

JF - Clinical Lymphoma, Myeloma and Leukemia

SN - 2152-2650

IS - 6

ER -